Trial · NCT02194634
Safety and Efficacy Study of Conbercept in Diabetic Macular Edema (DME) (Sailing)
NCT02194634, Phase 3, Unknown, Chengdu Kanghong Biotech Co., Ltd.
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Safety and Efficacy Study of Conbercept in Diabetic Macular Edema (DME) (Sailing). Trials, record NCT02194634. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02194634
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Safety and Efficacy Study of Conbercept in Diabetic Macular Edema (DME) (Sailing)
- NCT number
- NCT02194634
- Status
- Unknown
- Phases
- Phase 3
- Enrollment
- 248 participants, estimated
- Lead sponsor
- Chengdu Kanghong Biotech Co., Ltd.
- Conditions
- Diabetic Macular Edema
- Interventions
- Conbercept, Sham injection, Laser, Sham laser
- First posted
- 2014-07-18
- Last updated
- 2016-01-06
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Mean change from baseline in best corrected visual acuity (BCVA) at month 12 | Baseline and month 12 | To compare mean change from baseline BCVA between treatment group and controlled group at month 12. |
| Secondary | Mean change from baseline in central retinal thickness (CRT) between two groups | Baseline and month 12 | To compare mean change from baseline CRT between two groups at month 12. |
| Secondary | Safety (e.g. incidence of adverse events) of Conbercept ophthalmic injection | 12 months | To assess safety parameters during the study, such as incidence of adverse events , incidence of adverse drug reactions etc. |
| Other | Mean changes from baseline of photographic parameters, such as CRT, total macular volume and leakage area etc. | Baseline and every month, up to 12 months | |
| Other | Mean change from baseline BCVA between treatment group and controlled group | Baseline and every month, up to 12 months | |
| Other | Change from baseline in visual acuity distribution of treatment group and controlled group | Month 6, month 12 | |
| Other | The 25-item National Eye Institute Visual Function Questionnaire （NEI VFQ-25）total score mean change from baseline of between treatment group and controlled group | Month 6, month 12 |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 34001667 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02194634
GET https://conductscience.org/api/trials/v1/NCT02194634/registered